When.com Web Search

  1. Ads

    related to: vabysmo generic name price for dogs near me zip code location 30680

Search results

  1. Results From The WOW.Com Content Network
  2. Faricimab - Wikipedia

    en.wikipedia.org/wiki/Faricimab

    Faricimab, sold under the brand name Vabysmo (/ v ə ˈ b aɪ z m oʊ / və-BYEZ-mow), is a monoclonal antibody used for the treatment of neovascular age-related macular degeneration (nAMD) and diabetic macular edema (DME).

  3. FDA Approves First Injectable Eye Medicine For Vision Loss ...

    www.aol.com/news/fda-approves-first-injectable...

    Vabysmo is the first and only FDA-approved injectable eye medicine for wet AMD and DME that improves and. The FDA has approved Genentech's, a unit of Roche Holdings AG (OTC: RHHBY), Vabysmo ...

  4. List of generic and genericized trademarks - Wikipedia

    en.wikipedia.org/wiki/List_of_generic_and...

    Often used by consumers in the U.S. as if it were generic; "Onesies" is still a legally trademarked brand name of Gerber Childrenswear, which objects to its usage in the singular form as "Onesie" or as a generic product name. [163] Recently used to describe an adult bodysuit. [164] Pampers: Diapers: Procter & Gamble

  5. Oclacitinib - Wikipedia

    en.wikipedia.org/wiki/Oclacitinib

    Oclacitinib, sold under the brand name Apoquel among others, is a veterinary medication used in the control of atopic dermatitis and pruritus from allergic dermatitis in dogs at least 12 months of age. [1] [4] Chemically, it is a synthetic cyclohexylamino pyrrolopyrimidine janus kinase inhibitor that is relatively selective for JAK1. [5]

  6. Roche shares fall on modest 2024 outlook - AOL

    www.aol.com/news/roche-forecasts-return-growth...

    LONDON/FRANKFURT (Reuters) -Roche shares fell more than 4% on Thursday as the market expressed disappointed with the company's more modest than expected 2024 outlook. Sales in 2023 rose 1% when ...

  7. Pimobendan - Wikipedia

    en.wikipedia.org/wiki/Pimobendan

    Pimobendan is indicated for the management of the signs of mild, moderate, or severe congestive heart failure in dogs due to clinical myxomatous mitral valve disease (MMVD) or dilated cardiomyopathy (DCM); [1] [7] and for use with concurrent therapy for congestive heart failure (e.g.,furosemide, etc.) as appropriate on a case-by-case basis. [1]